Aurinia Pharmaceuticals Inc. - 10-Q Filing
Aurinia Pharmaceuticals Inc. filed its 10-Q for the quarter ended March 31, 2026, reporting $41.0 million in cash, cash equivalents, and restricted cash as of March 31, 2026, compared to $80.2 million as of December 31, 2025. The company held $337.8 million in short-term investments as of March 31, 2026, up from $317.8 million in the prior quarter. Total assets were $724.0 million as of March 31, 2026, compared to $751.6 million as of December 31, 2025.
Tickers: $AUPH